Article Details
Retrieved on: 2025-01-21 18:59:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Obstructive Sleep Apnea and Hypertension Update: FDA Clears Phase 2 Trial of Lorundrostat, an Oral Aldosterone Synthase Inhibitor. Jan 17, 2025. By ...
Article found on: www.patientcareonline.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here